
Exploring antibody stability through light scattering and calorimetry techniques
Tuesday, October 7, at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT
High-concentration antibody formulations are revolutionizing patient care by enabling convenient, self-administered subcutaneous dosing. But behind this flexibility lies a growing challenge to ensure stability, efficacy, and manufacturability in increasingly complex formulations.
Join Dr. Christine Nervig of TA Instruments and Dr. Sophia Kenrick of Waters | Wyatt Technology for an in-depth exploration of advanced analytical tools that are reshaping formulation development. This webinar will focus on strategies for assessing antibody stability and demonstrate how you can make faster, data-driven decisions in the development of stable and effective biologics.
Who should attend?
- Formulation scientists, protein engineers, and analytical teams working on high-concentration biologics, with a focus on aggregation, conformational, and conformational stability.
- Biopharmaceutical R&D leaders and project managers seeking streamlined, orthogonal approaches to accelerate decision-making across the biologics development pipeline.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers



What will this webinar cover?
- Understand how protein stability influences candidate and formulation selection during biotherapeutic development.
- Recognize the benefits of high-throughput analysis for accelerating workflows in the biopharmaceutical industry.
- Learn how dynamic and static light scattering (DLS/SLS) and rapid screening-differential scanning calorimetry (RS-DSC) can be applied to comprehensively assess thermal, colloidal, and long-term stability.
Join the webinar to get answers to these questions:
- How does protein stability guide candidate and formulation selection in biotherapeutic development?
- What advantages does high-throughput analysis offer for biopharmaceutical workflows?
- How can DLS/SLS be used to evaluate colloidal and aggregation stability in high-concentration antibodies?
- In what ways does RS-DSC support rapid screening of thermal stability in biologic formulations?
- How can combining DLS/SLS and RS-DSC improve predictions of long-term stability and manufacturability?
